HEPATIC CANCER STAGE II

HEPATIC CANCER STAGE II was reported 394 times

HEPATIC CANCER STAGE II is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-17A Antagonist [EPC] 1 0.0000
1 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
2 GLP-1 Receptor Agonist [EPC] 1 0.0000
3 Tumor Necrosis Factor Blocker [EPC] 1 0.0000